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Abstract
BACKGROUND: Past research has shown discrepancies between the time of symptom onset for patients
with acute coronary syndrome (ACS) as documented in the medical record (MR) and patients' recall of the
time assessed through subject interviews done later by researchers.
PURPOSE: The aim of this study is to determine if there were differences between the time of symptom onset
documented in the MR and subject interview taking into consideration sex, age group, and recall period for
patients admitted to the emergency department for symptoms suggestive of ACS.
METHODS: A secondary analysis was conducted on data from the PROMOTION (Patient Response to
Myocardial Infarction Following a Teaching Intervention Offered by Nurses) trial, a multicenter randomized
clinical trial to reduce patient prehospital delay to treatment in ACS.
RESULTS: Of the 3522 subjects with CAD enrolled into the trial, 3087 subjects completed 2-year follow-up.
Of these, 331 subjects sought treatment in the emergency department for ACS symptoms and 276 patients
(83%) had complete information on the time of symptom onset from both sources. Of the 276 patients, 25
(9%) had differing times more than 48 hours and were thus excluded. The median difference between the 2
sources was 45.0 minutes. When both times were examined, there were no significant differences in time by
sex (P = .720) or by age group (P = .188). The median number of days between the interview and the date of
symptom onset was 29.5 days. There was a significant correlation between differences in the time of symptom
onset and the length of recall period (rs = 0.148, P = .023). In multivariable modeling, a longer recall period
was associated with greater median differences in the symptom onset time (b = 13.2, P = .023).
CONCLUSION: These results suggest that the time of symptom onset obtained at the time of the index event
and documented in the MR is not interchangeable with data obtained later by research staff, especially if the
interview is not conducted near the time of the index event.
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Abstract
Background—Past research has shown discrepancies between the time of symptom onset for 
patients with acute coronary syndrome (ACS) as documented in the medical record (MR) and 
patients’ recall of the time assessed through subject interviews done later by researchers.
Purpose—To determine if there were differences between the time of symptom onset 
documented in the MR and subject interview taking into consideration gender, age group, and 
recall period for patients admitted to the emergency department (ED) for symptoms suggestive of 
ACS.
Methods—A secondary analysis was conducted on data from the PROMOTION (Patient 
Response tO Myocardial Infarction fOllowing a Teaching Intervention Offered by Nurses) trial, a 
multi-center randomized clinical trial to reduce patient prehospital delay to treatment in ACS.
Results—Of the 3,522 subjects with CAD enrolled into the trial, 3,087 subjects completed 2-
year follow-up. Of these, 331 subjects sought treatment in the ED for ACS symptoms and 276 
patients (83%) had complete information on the time of symptom onset from both sources. Of the 
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276 patients, 25 (9%) had differing times > 48 hours, thus were excluded. The median difference 
between the two sources was 45.0 minutes. When both times were examined, there were no 
significant differences in time by gender (p = 0.720) or by age group (p = 0.188). The median 
number of days between the date of symptom onset and the interview was 29.5 days. There was a 
significant correlation between differences in the time of symptom onset and the length of recall 
period (rs = 0.148, p = 0.023). In multivariable modeling, a longer recall period was associated 
with greater median differences in the symptom onset time (b = 13.2, p = 0.023).
Conclusion—These results suggest that the time of symptom onset obtained at the time of the 
index event and documented in the MR is not interchangeable with data obtained later by research 
staff, especially if the interview is not conducted near the time of the index event.
Keywords
symptom onset; medical record; interview; congruence; acute coronary syndrome
Introduction
The time of symptom onset for patients with acute coronary syndrome (ACS) is frequently 
used to calculate total ischemic time, defined as the time of symptom onset to the time of the 
first coronary artery balloon inflation.1 Total ischemic time could be influenced by patient-
related delays, such as when patients fail to recognize and act upon symptoms of ACS, or 
hospital-related delays, such as when clinicians fail to diagnose patients in a timely manner 
once they enter the health care system. Either type of delay influences whether patients with 
ACS are eligible for acute reperfusion therapy. The longer the total ischemic time, the larger 
the infarction and worse the patient outcomes are. For example, total ischemic time has been 
shown to correlate better with infarct size and mortality compared to the door-to-balloon 
time interval in patients with ACS.1
Total ischemic time has been identified as one criterion of quality care for patients with 
ACS. Thus, accuracy in collecting and documenting this time interval by clinicians to 
maximize patient outcomes and demonstrate quality care is important. The time of the first 
coronary balloon inflation is relatively easy to define and obtain from the medical record 
(MR). However, a challenge remains in how consistent hospitals across the country 
operationally define the time of symptom onset with patients with symptoms of ACS. In 
fact, the American College of Cardiology Foundation/American Heart Association (ACCF/
AHA) Task Force on Clinical Data Standards advocates a consistent definition for the time 
of symptom onset as the time when the patient first notes ischemic symptoms lasting 10 
minutes or longer.2
In addition, cardiovascular researchers who investigate pre-hospital delay in patients with 
ACS frequently use the time of symptom onset to calculate prehospital delay time as an 
outcome variable for their research. When designing their studies, researchers have to decide 
whether to obtain these data from the MR, to interview subjects themselves, or to combine 
the two sources in order to obtain more complete data. Each source has the potential for 
measurement error. Some researchers consider the MR to be the “gold standard” since these 
data are collected and documented in “real time”, and thus are less subject to recall bias. 
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However, the MR is designed for clinical use; and data obtained from this source may be 
limited by legibility, completeness, and accessibility. Past studies have shown that the 
percentage of missing or incomplete symptom onset data in the MR for patients with acute 
myocardial infarction ranged from 14% to 40%.3–7 Furthermore, patients who are older and 
are female are more likely to have missing or incomplete time of symptom onset data in the 
MR.3
Other researchers prefer interviewing subjects first-hand to obtain the time of symptom 
onset, either in-person or by telephone after the index event. However, subject interviews 
done late in the course of care can be challenging. For example, subjects need to be willing, 
able, and available to participate. In addition, data collected by subject interviews done after 
the ACS event may also be lacking in completeness. For example, two studies reported the 
percentage of missing or incomplete data regarding the time of symptom onset from subject 
interviews ranged from 12–13%.6–7 Furthermore, using a combination of the two data 
sources is costly and resource intensive.
The question then is whether these data sources are interchangeable. Four studies conducted 
over a decade reported sizeable disagreements between the symptom onset time assessed 
during the index event as documented in the MR and the symptom onset time obtained by 
interview later after the event.4–7 However, two of the those studies were limited to patients 
with acute myocardial infarction and did not include patients with unstable angina (part of 
the full ACS spectrum).6–7 In addition, there have been a few changes in the past decade that 
warrant further investigation of this issues. For example, recently, there has been increased 
emphasis on assessing symptoms more broadly for atypical presentations (symptoms other 
than chest pain or pressure such as shortness of breath, diaphoresis, nausea, and pain or 
discomfort in the jaw, neck, back, arm, or upper abdomen). National initiatives from the 
American Heart Association such as Go Red for Women®8–9, which includes atypical 
symptom presentations in women, have broadened interview techniques by clinicians who 
assess patients in the acute setting. Also, outcomes-based quality improvement initiatives 
such as the American College of Cardiology/American Heart Association Acute Coronary 
Treatment and Intervention Outcomes Network (ACTION) Registry®/Get with the 
Guidelines™ (GWTG)10 program now track total ischemic time in relation to patient 
outcomes as a measure of quality of care in patients with ACS. Individual hospital reports 
for these initiatives include the percentage of missing data on issues such as the time of 
symptom onset thereby providing hospitals an opportunity to implement corrective measures 
to improve data collection and documentation. Given these new developments, the study 
reported here was designed to determine if there were currently differences between the 
times of symptom onset in the MR and subject interview, taken into consideration gender, 
age group, and recall period based on the date of the interview with patients admitted to the 
emergency department (ED) for symptoms suggestive of ACS.
Methods
This secondary analysis was conducted on data from the PROMOTION (Patient Response 
tO Myocardial Infarction fOllowing a Teaching Intervention Offered by Nurses) trial. The 
PROMOTION trial,11 a randomized clinical trial, tested a face-to-face intervention designed 
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to reduce patient delay in seeking treatment for ACS symptoms. Patients with a history of 
cardiac disease were enrolled, randomized to usual care or intervention and then followed 
for 2 years for occurrence of ACS symptoms. Patients were instructed to call the 
investigators (after the acute event was over) when they sought treatment for symptoms they 
believed were cardiac in origin. In the event that patients did not contact the investigators 
after an ED visit, patients were also telephoned every 6 months by investigators to discuss 
whether there had been any unreported ED visits for ACS. Patients who sought treatment for 
symptoms for presumed ACS were interviewed using techniques the investigators had 
developed to assist patients most closely determine the time of symptoms onset.
Sample
Of the 3,522 patients with a history of CAD were enrolled in the PROMOTION study, 3,087 
(88%) completed 2-year follow-up.11 Of these, 565 had ED admissions with symptoms 
suggestive of ACS.12 Of the 565, 331 (59%) were diagnosed with ACS (and these were 
included in the current study).12 Among these 331 patients, 11 (3%) were missing time of 
symptom onset in the MR and 48 (15%) were missing the time of symptom onset from 
subject interviews; thus 55 patients (17%) were missing data from either MR or subject 
interview.
A total of 276 patients (83%) had complete data from both sources. Of these patients for 25 
(9%), there was a difference of more than 48 hours in time of symptom onset reported in the 
MR and the interview. Because of this difference was so large, these patients were not 
included in the analysis. The remaining sample of 251 ACS patients is the focus of this 
report.
Data Analysis
Patient sample characteristics were assessed using descriptive statistics. Differences in time 
of symptom onset between the MR and interview were calculated in minutes (min) and were 
categorized as <30 min, 30–<60 min, 60–<90 min, and 90 min to 48 hours. Age at 
enrollment in the study was categorized as ≤65 years, 66–79 years, and ≥80 years. Gender 
and age groups’ time differences were assessed visually with boxplots and with Wilcoxon 
rank sum and Kruskal-Wallis nonparametric tests. Recall period for subject interviews was 
calculated as the number of days between the date of symptom onset and the date of subject 
interview. Recall period and differences in the time of symptom onset were graphically 
assessed using a scatterplot and LOESS smoother (LOcally WEighted Scatter-plot 
Smoother) and analyzed with Spearman rank correlations (rs). Multivariable median 
regression modeling13 was used to assess the associations of gender, age groups, and length 
of recall period (after log-transformation) with the time of symptom onset, adjusting for 
randomized group assignment and site. All analyses were performed in SAS v9.3 (SAS 
Institute, Cary, NC). A two-sided p < 0.05 was considered statistically significant.
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Results
The mean age at enrollment of the 251 patients at enrollment was 66.8 years (SD = 11.8). 
About a third (35%) were female. Fifteen (6%) patients had missing dates for interviews, so 
their recall period could not be calculated. Of the 236 who had dates for interviews, the 
median number of days between the date of symptoms onset and the interview was 29.5 
days (M = 83.9 days, SD = 129.4 days). Table 1 gives the characteristics of the patient 
sample.
Of the 251 subjects with complete data, the median difference between the two data sources 
for the time of symptom onset was 45.0 min (M = 303.1 min, SD = 530.3 min). See Table 2. 
There was no significant difference in the time of symptom onset between males and 
females (p = 0.72) for the two sources. The median difference between the two data sources 
in the time of symptom onset by age groups were 40.0 min for ≤65 years old, 40.0 min for 
66–79 years old, and 132.5 min for ≥80 years old; although these did not differ statistically 
(p = 0.188).
Greater differences in the time of symptom onset between the MR and the interview were 
associated with longer recall periods (see Figure 1). Specifically, there was a significant 
positive correlation between differences in the time from symptom onset and recall (rs = 
0.148, p = 0.023). Using multivariable median regression (see Table 3), there were no 
significant associations with differences between the two data sources in the time of 
symptom onset, except for log-transformed length of recall period (p = 0.023). Longer recall 
periods were significantly associated with greater differences in the time of symptom onset 
between the MR and interviews, adjusting for other model covariates (b = 13.2, 95% CI 
=[1.9, 24.6]). For example, interviews conducted 3 days after the event were associated with 
an 18–minute difference; interviews done 7 days afterwards were associated with a 27-
minute difference. If the recall period was greater than approximately 9 days the difference 
between the two data sources exceeded 30 minutes.
Discussion
We found significant discrepancies between the MR and patient interview in time of 
symptom onset, but with no definitive indication of which was more accurate. Notably, a 
longer recall period was associated with a greater difference in the two sources of 
information. Based on these findings, nearly half (49%) of the patients in this study had 
more than a 1-hour difference between the two data sources. As determined in this study, a 
median difference of 45 minutes between the two data sources is clinically meaningful given 
that past studies have shown that for every 30 minutes of prehospital delay there is a 7.5 % 
increase in mortality.14
We also found that in this study the percentage of missing symptom onset data was much 
lower in the MR as compared to subject interviews done after the index event (3% versus 
15%, respectively). In addition, this percentage of missing data in the MR in this study is 
markedly lower than that reported in prior studies (3% in current study versus 14–40%).3–7 
It is possible that the emergency department clinicians were educated in advance of the 
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PROMOTION study about the importance of documenting the time of symptom onset. 
However, the percentage of missing data from subject interviews in this study was about the 
same as reported in past studies (15% in current study versus 12–13%).5–6 One explanation 
for a higher percentage of missing data from subject interviews is that the median length of 
time between the index event and the subject interview was about a month (29.5 days). 
Although the interviews were conducted by trained researchers, the length of time between 
the actual event and the interview probably influenced patients’ ability to remember the time 
of symptom onset. Thus, we recommend that data from subject interviews not be used to 
collect the time of symptom onset if the interviews are not conducted within 72 hours of the 
hospital admission.
No differences by age or gender were noted related to discrepancies between the MR and the 
subject interview. One explanation for a lack of significant differences between the two data 
sources based on gender and age is that assessment techniques may have improved in patient 
groups that are more likely to have atypical symptoms (women and the elderly).
Strengths and Limitations
One strength of the study was that it is a multi-center international study that reported a low 
percentage of missing or incomplete data from the MR as compared to past studies in the 
literature. However, one limitation of this study is that the time of symptom onset from both 
data sources was from subject report provided retrospectively after the symptoms had 
occurred. Thus no direct observations were done to determine the exact time of symptom 
onset in real time.
Implications for Clinical Practice
Clinicians in acute and critical care settings face several challenges with obtaining an 
accurate time of symptom onset for patients presenting with suspected ACS, and must do so 
within a time sensitive context. Clinicians are first charged with ensuring that symptoms of 
ischemia are assessed broadly, beyond chest pain as a single symptom, to avoid missing a 
potential ACS diagnosis. Secondly, clinicians may encounter patients that have difficulty 
articulating their symptom experience based on the questions asked. For example, some 
patients may have symptoms that evolve gradually, making it difficult for them to pinpoint 
the exact time of onset. Other patients may have difficulty quantifying vague or atypical 
symptoms. To overcome these challenges there is need for a standardized evidence-based 
assessment procedure for patients with suspected ACS.15, 16 Use of a standardized procedure 
would decrease the variability in clinical practice and provide evidence-based care for all 
patients with suspected ACS. For example, DeVon and colleagues have developed a 13-item 
ACS symptom checklist to be used for both clinical assessment and research.17 The 
instrument has established reliability and validity for use as a rapid triage assessment tool 
and is suitable for integration in an electronic health record (EHR).17
Furthermore, incorporation of a standardized assessment procedure in the EHR has other 
potential advantages such as improving completeness of documentation of symptoms, 
including the time of symptom onset. Clinicians in acute and critical care settings have an 
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opportunity and an obligation to be champions in designing and utilizing efficient 
assessment data collection processes. Input by clinicians can include which data elements 
should be entered as structured data (e.g. quantifiable data such as systolic blood pressure or 
pain intensity level), discrete data in predefined categories (e.g. presence or absence of 
certain ACS symptoms), or as textual data (e.g. narrative data entered as free text).18 
Clinicians can also provide input into clinical decision support tools, such as “Smart” 
computer assisted data entry options which prompt clinicians to enter discrete data or 
double-check data entered (e.g. the EHR can pre-calculate the time of symptom onset to 
hospital arrival). Options for rephrasing assessment questions could be used if a patient has 
difficulty answering a specific question related to symptoms. Furthermore, “real-time” flags 
can be provided alerting the clinician that data are missing thus providing an opportunity to 
increase completeness of assessment and documentation during the initial patient 
encounter.18
Conclusion
The findings from this study provide important information on assessing the time of cardiac 
symptom onset. The two data sources (MR versus subject interviews done after the acute 
event) are clearly not interchangeable, especially if the interviews are done more than 3 days 
after the index event. These findings indicate that documentation of symptom onset time in 
the MR has improved compared to previous studies. However clinicians in acute and critical 
care settings should remain vigilant about accurate assessment and documentation of cardiac 
symptoms, especially in those patients with less discrete symptom onset.
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Figure 1. 
Scatterplot of time of symptom onset differences for medical record (MR) relative to subject 
interview (SI) versus length of recall period from subject interview for the 251 ACS patients 
with time of symptom onset of 48 hours or less
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